)
)
Hansoh Pharmaceutical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Hansoh Pharmaceutical Group
Access all reports
Hansoh Pharmaceutical Group is a Chinese pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative and generic drugs. The company’s product portfolio covers therapeutic areas such as oncology, central nervous system (CNS) disorders, anti-infectives, and diabetes. Hansoh Pharmaceutical places a strong emphasis on innovation, investing in R&D to expand its pipeline with both novel and high-quality generic drugs to address unmet medical needs. The company is headquartered in Lianyungang, China, and its shares are listed on the Hong Kong Stock Exchange.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
3692
Country
🇭🇰 Hong Kong